Gene fusions are common primary drivers of pediatric leukemias and are the result of underlying structural variants (SVs). Current clinical workflows to detect such alterations rely on a multimodal approach, which often increases analysis time and overall cost of testing. In this study, we used long-read sequencing (lrSeq) as a proof-of-concept to determine whether clinically relevant (cr) SVs could be detected within a small (n = 17) pediatric leukemia cohort. We show that this methodology successfully determined all known crSVs (n = 5/5) detected through routine clinical testing. This approach also identified crSVs that resulted in the classification of a leukemia genetic subtype for four additional patients (n = 4/12), such as an ins(11;10)(q23.3;p12p12) forming a KMT2A::MLLT10 fusion, that were missed by routine clinical approaches. This study demonstrates the diagnostic potential of lrSeq as an assay for SV detection in pediatric leukemia and supports lrSeq as a valuable tool for the accurate detection of crSVs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lisa A. Lansdon
Byunggil Yoo
Ayse Keskus
npj Genomic Medicine
National Institutes of Health
National Cancer Institute
University of Missouri–Kansas City
Building similarity graph...
Analyzing shared references across papers
Loading...
Lansdon et al. (Thu,) studied this question.
www.synapsesocial.com/papers/69db35be4fe01fead37c440e — DOI: https://doi.org/10.1038/s41525-026-00560-5